OncoMed pancreatic cancer drug wins FDA 'orphan' tag By: San Francisco Business Times via Business Journals May 02, 2014 at 14:37 PM EDT OncoMed Pharmaceuticals Inc. won orphan drug designation from the Food and Drug Administration for its lead experimental pancreatic cancer drug... Read More >> Related Stocks: Eli Lilly